Six offbeat destinations in Kashmir that offer unique experiences away from the usual tourist trails. Explore hidden gems and ...

Tanneries seek to reduce their environmental footprint; switching to solar power in the Himalayas, what could happen if crude ...

By 2022, India was number one in all formats. From lucrative media deals during pandemic, hosting world cup at home, salary ...

Whether you’re travelling solo, with your partner, or with family, these pro tips are all you need to make your time in Saudi ...

The red panda is a charismatic animal that’s shrouded in mystery and notoriously difficult to find, and therefore a perfect ...

When the Liberal government chopped a planned beer excise tax hike to two per cent from 4.5 per cent and froze ... The ...

Following president-elect Donald Trump's decisive election victory, there are sure to be significant knock-on effects for ...

The telecom operator narrowed its consolidated loss after tax to 71.76 billion rupees ($850.7 million) for the quarter ended ...

Nov 7 (Reuters) - Drugmaker Abbott India (ABOT.NS), opens new tab reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.

30, up nearly 15 percent from last year. Drugmaker Abbott India reported a rise in second-quarter profit on November 7, helped by strong demand for its gastrointestinal and anti-infective medications.